These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3974522)

  • 1. Tumor dose specification of I-125 seed implants.
    Wu A; Zwicker RD; Sternick ES
    Med Phys; 1985; 12(1):27-31. PubMed ID: 3974522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants.
    Yu Y; Waterman FM; Suntharalingam N; Schulsinger A
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):717-25. PubMed ID: 8621297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new power law for determination of total (125)I seed activity for ultrasound-guided prostate implants: clinical evaluations.
    Wu A; Lee CC; Johnson M; Brown D; Benoit R; Miler R; Cohen J; Geis P; Chen AS; Kalnicki S
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1397-403. PubMed ID: 10889395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorbed dose determination for interstitial 125I boost therapy.
    Waterman FM; Strubler KA
    Med Phys; 1983; 10(2):155-8. PubMed ID: 6865855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
    Nath S; Chen Z; Yue N; Trumpore S; Peschel R
    Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
    Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of prostate implants based on postimplant treatment margin assessment.
    Mueller A; Wallner K; Merrick G; Courveau J; Sutlief S; Butler W; Gong L; Cho P
    Med Phys; 2002 Dec; 29(12):2782-7. PubMed ID: 12512711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brachytherapy for prostate carcinoma].
    Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):87-91. PubMed ID: 15920966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
    Lindsay PE; Van Dyk J; Battista JJ
    Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of seed loading approaches in prostate brachytherapy.
    Butler WM; Merrick GS; Lief JH; Dorsey AT
    Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
    Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
    Meigooni AS; Luerman CM; Sowards KT
    Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of random seed placement error in permanent transperineal prostate seed implant.
    Bues M; Holupka EJ; Meskell P; Kaplan ID
    Radiother Oncol; 2006 Apr; 79(1):70-4. PubMed ID: 16515813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.